Clean systemic toxicity profile and no local side-effects following injection Tiny shock absorbing microparticles support and ...

Cardiogenic shock (CS) is a life-threatening condition leading to poor prognosis and high ... currently represents a concrete approach in such conditions considered hopeless in the past (Wang et al.).

The following is a summary of “Phosphodiesterase 3 inhibitors do not influence lactate kinetics and clinical outcomes in ...

Objective There is an amelioration in mortality rates of septic shock patients with malignancies over time, but it remains uncertain in children. Therefore, the authors endeavored to compare the ...

With a new administration coming in, advocates worry that the FDA may lose its sense of urgency to ban electrical shock ...

About 40 hospital support workers at Auckland Hospital and Greenlane Clinical Centre were called to a meeting last week and ...

The patent filing expands upon data obtained from animal model testing and the istaroxime human clinical trials in acute heart failure (AHF) and early cardiogenic shock (ECS), including the latest ...

Similarly, the Impella 5.5 with SmartAssist System is approved for short-term use of up to 14 days for paediatric patients ...

The framework seeks to make the UK a desirable clinical trials location by expediting approvals and raising participant ...

The lawyer helping Robert F. Kennedy Jr. pick health officials to serve in the upcoming Trump administration has petitioned ...

Daily assessment of procalcitonin (PCT), rather than standard care alone, led to patients spending significantly less time on ...